Saw Palmetto 320 mg by Doctor's Best — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size

60 Servings

Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Prosterol

320 mg

Other Ingredients

Softgel Capsule

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult Male (18-50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Adult Use: Take 1 daily with or without food, or as recommended by a nutritionally informed physician.

🧪 Formulation Notes

Doctor’s Best Saw Palmetto contains pure standardized saw palmetto extract guaranteed to supply 85% to 95% saw palmetto fatty acids and beneficial plant sterols, which are the herb's key active ingredients. Saw Palmetto has been widely studied for prostate-related urinary function. The extraction method used on this Saw Palmetto prevents solvent residues.

Helps support healthy function of the prostate gland and urinary tract.

Saw Palmetto Standardized Extract with Prosterol eUROMED Phyto Proof

Helps Support Healthy Prostate Function

Non-GMO Gluten Free Soy Free

This product contains natural ingredients that may vary in color.

Additional Information

Store in a cool dry place.

Product Details

UPC / SKU 7 53950 00082 7

DSLD Entry Date 2022-07-21

Product Type Botanical

Form Softgel Capsule

Brand Doctor's Best

DSLD ID 269286

Data Updated 2026-04-11

Research Evidence

35 Research Sources

52 Avg Quality Score

15 Meta Analysis

11 Systematic Review

7 Rct

1 Narrative Review

1 Openfda Safety

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2009

PubMed DOI

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis

Meta Analysis Investigative and clinical urology 2021

PubMed DOI

B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials

Systematic Review European urology focus 2021

PubMed DOI

B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene

Systematic Review European review for medical and pharmacological sciences 2019

PubMed DOI

B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Meta Analysis American journal of men's health 2020

PubMed DOI

B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

Systematic Review BJU international 2012

PubMed DOI

B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis